Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

The share buy-back program is expected to be realized in the period from February 26, 2025, to August 15, 2025. The total ...

Pandora announced a new share buyback programme, cf. Company announcement no. 923. The share buyback programme is executed in ...

Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.

Company Announcement Copenhagen, 12 May 2025 No. 31/2025 Reduction of share capital ISS A/S (the “Company”), a leading workplace experience and facility management company, today announces that the ...

Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...

Nini Pryds, Henning Friis Poulsen, Irini Angelidaki, and Leif Oxenløwe each received a prestigious Villum Investigator grant, ...

In accordance with Section 31 of the Capital Market Act, it is hereby announced that ISS A/S as of today owns a total of 3,087,915 treasury shares of nominally DKK 1, hence less than 5% of the total ...

Welcome to the 2022 DKK EUR history summary. This is the Danish Krone (DKK) to Euro (EUR) exchange rate history data page for the year of 2022, covering 365 days of DKK EUR historical data.

This year's grant recipients are younger health science researchers from both Denmark and abroad, all of whom hold a PhD in ...